Cargando…
An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment
SIMPLE SUMMARY: One of the important efforts in the treatment of cancers is to achieve targeted drug delivery by nanocarriers to be more effective and reduce adverse effects. However, due to the adverse responses of nanocarriers in clinical trials due to the very weak EPR effects, doubts have been r...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220781/ https://www.ncbi.nlm.nih.gov/pubmed/35740534 http://dx.doi.org/10.3390/cancers14122868 |